Risk factors for recurrence following complete cytoreductive surgery and HIPEC in colorectal cancer-derived peritoneal surface malignancies

Langenbeck's Archives of Surgery

Volumn 398, Issue 5, 2013, Pages 745-749

  Königsrainer, Ingmar ^a   Horvath, Philipp ^a   Struller, Florian ^a   Forkl, Viola ^a   Königsrainer, Alfred ^a   Beckert, Stefan ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

HIPEC; Peritoneal surface malignancy; Recurrence

Indexed keywords

MITOMYCIN;

ABDOMINAL SURGERY; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RECURRENCE; COLORECTAL CANCER; CYTOREDUCTIVE SURGERY; FEMALE; FOLLOW UP; HUMAN; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; MAJOR CLINICAL STUDY; MALE; METASTASIS; ONCOLOGICAL PARAMETERS; PERITONEAL SURFACE MALIGNANCY; PERITONECTOMY; PERITONEUM CANCER; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT CANCER; TUMOR LOAD;

ADOLESCENT; ADULT; AGED; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; PERITONEAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; REOPERATION; RETROSPECTIVE STUDIES; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84877753871     PISSN: 14352443     EISSN: 14352451     Source Type: Journal    
DOI: 10.1007/s00423-013-1065-6     Document Type: Article

References (18)

1. Glehen O, Gilly FN, Boutitie F, Bereder JM, Quenet F, Sideris L, Mansvelt B, Lorimier G, Msika S, Elias D (2010) Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients. Cancer 116:5608-18
2. Yan TD, Morris DL (2008) Cytoreductive surgery and perioperative intraperitoneal chemotherapy for isolated colorectal peritoneal carcinomatosis: experimental therapy or standard of care? Ann Surg 248:829-835
3. Sugarbaker PH (1988) Surgical management of peritoneal carcinosis: diagnosis, prevention and treatment. Langenbecks Arch Chir 373:189-96
4. Sugarbaker PH (1995) Patient selection and treatment of peritoneal carcinomatosis from colorectal and appendiceal cancer. World J Surg 19:235-40
5. Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, Zoetmulder FA (2003) Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21:3737-43
6. Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H (2008) Eight-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 15:2426-2432
7. Chua TC, Yan TD, Smigielski ME, Zhu KJ, Ng KM, Zhao J, Morris DL (2009) Long-term survival in patients with pseudomyxoma peritonei treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy: 10 years of experience from a single institution. Ann Surg Oncol 16:1903-11
8. Bijelic L, Yan TD, Sugarbaker PH (2007) Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer. Ann Surg Oncol 14:2281-8
9. Verwaal VJ, Boot H, Aleman BM, van Tinteren H, Zoetmulder FA (2004) Recurrences after peritoneal carcinomatosis of colorectal origin treated by cytoreduction and hyperthermic intraperitoneal chemotherapy: location, treatment, and outcome. Ann Surg Oncol 11:375-9
10. Elias D, Goéré D, Di Pietrantonio D, Boige V, Malka D, Kohneh-Shahri N, Dromain C, Ducreux M (2008) Results of systematic second-look surgery in patients at high risk of developing colorectal peritoneal carcinomatosis. Ann Surg 247:445-50
11. Sugarbaker PH (1995) Peritonectomy procedures. Ann Surg 221:29-42
12. Jacquet P, Sugarbaker PH (1996) Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 82:359-74
13. Pelz JO, Stojadinovic A, Nissan A, Hohenberger W, Esquivel J (2009) Evaluation of a peritoneal surface disease severity score in patients with colon cancer with peritoneal carcinomatosis. J Surg Oncol 99:9-15
14. Kraemer M, Wiratkapun MD, Seow-Choen F, Ho YH, Eu KW, Nyam D (2001) Stratifying risk factors for follow-up: a comparison of recurrent and nonrecurrent colorectal cancer. Dis Colon Rectum 44:815-821
15. Thomson WH, Foy CJ, Longman RJ (2008) The nature of local recurrence after colorectal cancer recurrence. Color Dis 10:69-74
16. Günther K, Dworak O, Remke S et al (2002) Prediction of distant metastases after curative surgery for rectal cancer. J Surg Res 103:68-78
17. Cusack JC, Giacco GG, Cleary K, Davidson BS, Izzo F, Skibber J, Yen J, Curley SA (1996) Survival factors in 186 patients younger than 40 years old with colorectal adenocarcinoma. J Am Coll Surg 183:105-12
18. Nissan A, Guillem JG, Paty PB, Wong WD, Cohen AM (1999) Signet-ring cell carcinoma of the colon and rectum: a matched control study. Dis Colon Rectum 42:1176-80